NASDAQ: STOK · Health Care / Biotechnology: Pharmaceutical Preparations

Stoke Therapeutics Inc.

How Stoke Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap
$1.7B
Price
$26.35
P/E
-7.9
EPS (TTM)
$-3.33
1-year return
-16.1%
Dividend yield
0.0%
52-week range
$22.50–$27.93

Compared with

For information only, not investment advice. Data may contain errors. Disclaimer · Sources